Neurocrine Biosciences Inc (NBIX)
Total asset turnover
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 2,355,300 | 2,241,400 | 2,117,000 | 1,978,200 | 1,882,900 | 1,779,300 | 1,668,300 | 1,522,900 | 1,411,600 | 1,306,100 | 1,208,800 | 1,185,500 | 1,107,700 | 1,050,200 | 1,010,800 | 1,022,200 | 1,020,900 | 1,017,010 | 981,066 | 862,604 |
Total assets | US$ in thousands | 3,718,700 | 3,535,000 | 3,305,000 | 3,472,400 | 3,251,400 | 2,848,200 | 2,613,100 | 2,359,800 | 2,368,700 | 2,143,400 | 2,005,700 | 2,144,500 | 2,072,500 | 2,017,300 | 1,956,400 | 1,846,400 | 1,734,700 | 1,502,600 | 1,515,600 | 1,361,900 |
Total asset turnover | 0.63 | 0.63 | 0.64 | 0.57 | 0.58 | 0.62 | 0.64 | 0.65 | 0.60 | 0.61 | 0.60 | 0.55 | 0.53 | 0.52 | 0.52 | 0.55 | 0.59 | 0.68 | 0.65 | 0.63 |
December 31, 2024 calculation
Total asset turnover = Revenue (ttm) ÷ Total assets
= $2,355,300K ÷ $3,718,700K
= 0.63
The total asset turnover ratio measures how efficiently a company generates revenue from its assets. A higher ratio indicates that the company is effectively utilizing its assets to generate sales.
Looking at Neurocrine Biosciences Inc's total asset turnover over the past few years, there is a fluctuating trend. The ratio ranged between 0.52 and 0.68 during the period from March 31, 2020, to December 31, 2024.
In the most recent period of December 31, 2024, the total asset turnover was 0.63, which suggests that the company generated $0.63 in revenue for every dollar of assets it had during that time. This indicates a moderate efficiency in asset utilization compared to previous periods.
It is important for Neurocrine Biosciences Inc to monitor its total asset turnover ratio closely to ensure that the company is effectively managing its assets and maximizing revenue generation. Any significant deviations in the ratio could warrant further investigation into the company's operational efficiency and asset management strategies.
Peer comparison
Dec 31, 2024